Det primære effektmål var andelen af patienter, som "responderede" på behandlingen inden for 12 uger, dvs. hvis symptomscore forbedredes med mindst 75%.
The main measure of effectiveness was the number of patients who ‘ responded ’ to treatment after 12 weeks, meaning that symptom scores improved by 75% or more.